JRCT ID: jRCT2080221268
Registered date:18/10/2010
Basic Information
Recruitment status | |
---|---|
Health condition(s) or Problem(s) studied | Uncontrollable cancer pain |
Date of first enrollment | 18/10/2010 |
Target sample size | |
Countries of recruitment | |
Study type | Interventional |
Intervention(s) | investigational material(s) Generic name etc : TK-642 INN of investigational material : Methadone Hydrochloride Therapeutic category code : 821 Synthetic narcotics Dosage and Administration for Investigational material : Oral |
Outcome(s)
Primary Outcome | Efficacy and Safety |
---|---|
Secondary Outcome |
Key inclusion & exclusion criteria
Age minimum | >= 20age old |
---|---|
Age maximum | <= 74age old |
Gender | Both |
Include criteria | 1)Japanese cancer patients who can be hospitalized for clinical trial 2)Patients who are 20-74 years old at the time of informed consent 3)Patients who have been received cancer pain therapy with opioid for over 1 week etc. |
Exclude criteria | 1)Patients who have any complications or history of cardiac conduction disturbance 2)Patients who have any complications or history of abnormality of respiratory function 3)Patients with any organic encephalopathies etc. |
Related Information
Primary Sponsor | TEIKOKU SEIYAKU CO., LTD. |
---|---|
Secondary Sponsor | |
Source(s) of Monetary Support | |
Secondary ID(s) | JapicCTI-101305 |
Contact
Public contact | |
Name | |
Address | rinsho@teiyaku.co.jp |
Telephone | |
Affiliation | TEIKOKU SEIYAKU CO., LTD. |
Scientific contact | |
Name | |
Address | |
Telephone | |
Affiliation |